How Ebola and Marburg viruses battle the immune system (Q36858879)

16 August 2017

1 reference

title

How Ebola and Marburg viruses battle the immune system (English)

1 reference

16 August 2017

Orthoebolavirus zairense

0 references

0 references

3

Alan L Schmaljohn

1 reference

16 August 2017

1

Mansour Mohamadzadeh

1 reference

16 August 2017

Lieping Chen

2

1 reference

16 August 2017

1 July 2007

1 reference

Nature Reviews Immunology

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

7

1 reference

16 August 2017

556-567

1 reference

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

16 August 2017

1 reference

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses

21 January 2018

1 reference

In vivo generation of pathogen-specific Th1 cells in the absence of the IFN-gamma receptor.

21 January 2018

1 reference

Evaluation in nonhuman primates of vaccines against Ebola virus

21 January 2018

1 reference

Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages

21 January 2018

1 reference

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

31 March 2020

1 reference

An analysis of features of pathogenesis in two animal models of Ebola virus infection

31 March 2020

1 reference

Ebola virus: from discovery to vaccine

31 March 2020

1 reference

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

31 March 2020

1 reference

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry

31 March 2020

1 reference

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

31 March 2020

1 reference

Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses

31 March 2020

1 reference

Syndecan captures, protects, and transmits HIV to T lymphocytes

31 March 2020

1 reference

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

31 March 2020

1 reference

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein

31 March 2020

1 reference

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

31 March 2020

1 reference

Filoviruses and the balance of innate, adaptive, and inflammatory responses

31 March 2020

1 reference

Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction

31 March 2020

1 reference

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

31 March 2020

1 reference

Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation

31 March 2020

1 reference

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

31 March 2020

1 reference

Type I interferons keep activated T cells alive

31 March 2020

1 reference

Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.

31 March 2020

1 reference

Infection and activation of monocytes by Marburg and Ebola viruses

31 March 2020

1 reference

Role of natural killer cells in innate protection against lethal ebola virus infection

31 March 2020

1 reference

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

31 March 2020

1 reference

Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence

31 March 2020

1 reference

The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha

31 March 2020

1 reference

Neutrophils and immunity: challenges and opportunities

31 March 2020

1 reference

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

31 March 2020

1 reference

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

31 March 2020

1 reference

Ectodomain shedding of the glycoprotein GP of Ebola virus

31 March 2020

1 reference

Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage.

31 March 2020

1 reference

Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)

31 March 2020

1 reference

Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates

31 March 2020

1 reference

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

31 March 2020

1 reference

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

31 March 2020

1 reference

Inflaming the CD8+ T cell response.

31 March 2020

1 reference

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

31 March 2020

1 reference

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

31 March 2020

1 reference

Therapeutic opportunities in the B7/CD28 family of ligands and receptors

31 March 2020

1 reference

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

31 March 2020

1 reference

PD-1 inhibits antiviral immunity at the effector phase in the liver

31 March 2020

1 reference

Restoring function in exhausted CD8 T cells during chronic viral infection

31 March 2020

1 reference

B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression

31 March 2020

1 reference

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

31 March 2020

1 reference

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

31 March 2020

1 reference

Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques

31 March 2020

1 reference

Human asymptomatic Ebola infection and strong inflammatory response

31 March 2020

1 reference

Inflammatory responses in Ebola virus-infected patients.

31 March 2020

1 reference

Programming, demarcating, and manipulating CD8+ T-cell memory.

31 March 2020

1 reference

Toward an understanding of NKT cell biology: progress and paradoxes

31 March 2020

1 reference

The NKT cell system: bridging innate and acquired immunity

31 March 2020

1 reference

A novel dendritic cell subset involved in tumor immunosurveillance

31 March 2020

1 reference

Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).

31 March 2020

1 reference

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

31 March 2020

1 reference

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

31 March 2020

1 reference

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

31 March 2020

1 reference

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

31 March 2020

1 reference

Immunization for Ebola virus infection

31 March 2020

1 reference

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

31 March 2020

1 reference

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

31 March 2020

1 reference

Experimental therapy of filovirus infections

31 March 2020

1 reference

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys

31 March 2020

1 reference

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

31 March 2020

1 reference

Epitopes involved in antibody-mediated protection from Ebola virus

31 March 2020

1 reference

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

31 March 2020

1 reference

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

31 March 2020

1 reference

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

31 March 2020

1 reference

Persistent infection with ebola virus under conditions of partial immunity

31 March 2020

1 reference

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

31 March 2020

1 reference

The evolving field of biodefence: therapeutic developments and diagnostics

31 March 2020

1 reference

Development of a preventive vaccine for Ebola virus infection in primates

31 March 2020

1 reference

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

31 March 2020

1 reference

A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge

31 March 2020

1 reference

Successful topical respiratory tract immunization of primates against Ebola virus

31 March 2020

1 reference

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

31 March 2020

1 reference

Effective post-exposure treatment of Ebola infection

31 March 2020

1 reference

Molecular determinants of Ebola virus virulence in mice

31 March 2020

1 reference

Experimental inoculation of plants and animals with Ebola virus

31 March 2020

1 reference

Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade

31 March 2020

1 reference

Fruit bats as reservoirs of Ebola virus

31 March 2020

1 reference

Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola

31 March 2020

1 reference

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients

31 March 2020

1 reference

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

31 March 2020

1 reference

Hemorrhagic fever viruses as biological weapons: medical and public health management

31 March 2020

1 reference

Marburg virus vaccines: comparing classical and new approaches

31 March 2020

1 reference

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

31 March 2020

1 reference

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

31 March 2020

1 reference

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

31 March 2020

1 reference

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

31 March 2020

1 reference

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

31 March 2020

1 reference

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

31 March 2020

1 reference

Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes

31 March 2020

1 reference

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses

31 March 2020

1 reference

Covalent modifications of the ebola virus glycoprotein

31 March 2020

1 reference

Polymorphism of Filovirus Glycoproteins

31 March 2020

1 reference

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

31 March 2020

1 reference

Comprehensive analysis of ebola virus GP1 in viral entry

31 March 2020

1 reference

Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain

31 March 2020

1 reference

Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor

31 March 2020

1 reference

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

31 March 2020

1 reference

The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins

31 March 2020

1 reference

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRI2098

1 reference

16 August 2017

1 reference

PubMed ID

17589545